Dr. Kunwoo Lee is the Co-Founder and CEO of GenEdit. He is an innovator and believer of gene therapy. He is the inventor of several delivery technologies for gene therapy including CRISPR gene editing. Prior to GenEdit, he completed graduate research at UC Berkeley in the Department of Bioengineering. He was named as a Forbes 30 under 30 in 2017 and was a Siebel Scholar in 2016.